Background: Obstructive sleep apnoea syndrome is a common condition for which continuous positive airways pressure (CPAP) is the standard treatment. The condition affects a population of which a substantial proportion will be travelling. Methods: We use a questionnaire survey of CPAP users to gain understanding regarding the behaviours, attitudes and problems surrounding travel with CPAP machines during travel and while abroad. All CPAP patients on our database at a UK district general hospital reviewed over a period of 4 years were sent a postal questionnaire. Results: A response rate of 53% was achieved giving data on 588 trips. In the last 2 years, 63.7% of respondents had travelled; reasons for not travelling were CPAP related in only five cases. Travellers took their CPAP machines on 81% of trips. A similar proportion of patients took their CPAP machines regardless of the mode of travel, destination or length of holiday. Problems with checking in the CPAP machine were encountered in 4% of trips, all as part of air travel. Just over a third of patients faced problems either with the power cord, adapter or transport of the CPAP machine. Of those taking overnight flights, half did not sleep and none used their CPAP machines in flight. CPAP usage while away did not differ to usage at home. Conclusions: This is the first report to describe in some detail CPAP machine use and associated problems in travel and while away. The data may aid the targeting of brief interventions in CPAP clinics as well as helping to standardize the process of check-in in order to help travellers with CPAP machines.
Introduction
Obstructive sleep apnoea syndrome (OSAS) is a common condition with a prevalence in the UK of 4% in men and 2% in women and is effectively treated with nocturnal use of continuous positive airways pressure (CPAP). 1 The condition affects a relatively young population of which a substantial proportion will be working and travelling, both for business and pleasure. The number of passengers choosing to travel by air is large and increasing. UK airports handled 235 million passengers in 2008 and UK residents made 65.7 million visits abroad in 2015, 5.1% more than the previous year. 2, 3 The increasing number of people choosing to fly inevitably means a greater variety in air passengers, including those with respiratory diseases. 4, 5 Previous studies have estimated that 5% of air travellers have respiratory disease and it is likely that this proportion will continue to rise with time. 6 A study of OSAS patients reported in conference proceedings has shown that 86% travel abroad and despite travel being considered a barrier to compliance with CPAP 82% of those that travel take their CPAP machines with them. 7 We have reported broadly similar figures earlier. 8 An article from 1994 stated that travelling with equipment such as CPAP machines would 'require much energy and courage' but the above figure demonstrates the large change in attitudes, and, more importantly, technology in this field during this time. 9 Although attitudes are changing the problems encountered by OSAS patients travelling with their CPAP machines have not been studied in any detail despite the high prevalence of the condition. The British Thoracic Society (BTS) has put forth guidelines on managing patients with respiratory disease planning air travel. 2 The main emphasis of these guidelines is based on the flight environment and the effect of altitude; commercial aircrafts are pressurized up to cabin altitudes of 8000 feet resulting in decrease in partial pressure of oxygen as compared to that at sea level. The effect of this and the physiological changes that take place has been studied in patients with Chronic Obstructive Pulmonary Disease predominantly and to a lesser extent in other conditions. The transmission of infections, such as tuberculosis and influenza, has also been evaluated. Very little is known about the effects of air travel in OSAS and this is reflected in these guidelines as well. These guidelines recommend that further research is needed into the proportion of patients using CPAP machines in-flight and the problems they encounter, along with whether CPAP users sleep inflight or avoid sleeping. 2 Indeed the research recommendations on OSAS far outweigh, as a proportion, actual recommendations on air travel and OSAS in these guidelines.
To our knowledge this is the first study focussed on elucidating some of these queries regarding CPAP use and travel and here we aim to add to the very small amount of data available on this subject. We use a questionnaire survey of CPAP users with the aim to gain understanding regarding the behaviours and attitudes surrounding travel with CPAP machines along with the problems encountered by CPAP users during travel and whilst away from home. The objective was to acquire data which may form the basis on which to inform patients, healthcare practitioners and travel industry representatives as to the nature and scale of this issue.
Methods
All patients in our database at a busy UK district general hospital that were reviewed whilst on CPAP over a period of 4 and a half years were sent a postal questionnaire (n = 738). They were asked the number of times they had travelled in the last 2 years and specific questions about the last three trips. These included mode of travel, duration of trip, change in CPAP use, issues during transport and use of CPAP. Patients were asked to specifically document whether they used CPAP during travel. All patients are routinely offered a letter regarding their CPAP therapy to facilitate travel. We used the hospital OSA database to calculate the patient's compliance in terms of hours per night (HPN) CPAP usage at home and compared it with self-reported use on holiday. Returned data was then collated and analysed by the authors using Microsoft Excel. Data is presented descriptively and relationship between categorical variables was evaluated using the chi-square test, where applicable. This study was approved by the Mid Yorkshire Hospitals NHS Trust.
Results
Of the 738 [males 81%, mean age 55.8 years (SD: 11.2)] questionnaires sent out 394 (53%) were returned. Of these 326 (83%) were men and the mean age was 59 years (SD: 10.2 years). They had a mean time on CPAP of 4.5 years (SD: 2.6) and a mean compliance (measured by CPAP HPN) of 6.63 (SD: 2.1). In the last 2 years 251 (63.7%) of these patients had travelled and 143 had not. There was no significant difference in the age, years on CPAP or compliance (HPN) between the travellers and non-travellers although significantly more women travelled as compared to men (20% vs 11%, P = 0.03) ( Table 1 ). These 251 patients had travelled on 879 occasions in the last 2 years with the mean number of trips being 3.5, and gave us data on 588 trips. Of these 416 were by air, 65 by road and 32 by ferry with the remainder via other forms of transport.
Travellers took their CPAP machines on 479 of the 588 trips (81%). The length of holiday was >2 weeks in 196 trips, 2 weeks in 127 and less or not specified in the remainder. The most popular destinations were Europe (n = 348), UK (n = 63) and North America (n = 47). A very similar proportion of patients took their CPAP machines regardless of the mode of travel, the destination or the length of holiday. Patients who had been on CPAP <2 years took their machines on 100% of trips (20 trips). Patients on CPAP 2-3 years and 3-4 years packed their machines a very similar proportion of times (68% and 69%, respectively) whereas those who had used CPAP 4-8+ years packed their machines in the vast majority of cases (4-5 years 93%, 5-6 years 98%, 6-8 years 95% and 8+ years 99%), with the differences between the groups being significant (P < 0.01). Of the 143 non-travellers only five (all males) stated that the reason was CPAP related; individual comments included 'was not sure CPAP could be used abroad', 'too much nuisance to travel with CPAP' and 'too much nuisance to travel as other health problems'.
A total of 69 trips were made without CPAP by 35 respondents. Of these patients who did not take their machines 54% stated that they thought that they would have problems getting the machine checked in, 47% considered they would have problems transporting the machine and 36% stated that space was limited and that they would rather take alternative items.
Of the 479 trips where check-in of baggage was applicable patients had problems with getting their CPAP machine into the hold or into the cabin (checking-in) in 20 cases (4%), but none had to leave the CPAP machine behind. All of these problems occurred during air travel; 16 involved taking the machine as hand luggage and four as hold luggage. Of all air travellers 86% (n = 308) took their CPAP machines as hand luggage. Patients on 351 of the 479 applicable trips had our CPAP letter. In 11.7% of these trips patients stated that they needed the letter (n = 56), 51 of these cases took place as part of air travel. Overall, 99 of the 416 flights (23.8%) in our data were reported as overnight flights. Of these patients reported having no sleep on 50 occasions. Of the remaining 49 flights on which patients reported sleeping all were without CPAP. The use of CPAP (HPN) did not significantly change pre-trip compared to during the trip (Table 2 ). In terms of problems whilst away, during 137 trips (26.4%) patients found the power cord for the CPAP machine too short, on 53 trips there were problems with transport (10.2%) and on seven trips (1.3%) problems were caused by forgetting to bring a power adapter. The most common combination of problems was cord length and transport and was encountered in 22 trips (4.2%).
Discussion
Our data shows a population of OSAS patients who are predominantly male and middle aged with good compliance with their CPAP regimen and of which the majority (63.7%) travel. Aside from containing a greater proportion of women, the travelling and non-travelling groups did not differ significantly in terms of age, years using CPAP or compliance. Our respondents took their CPAP machines on over three-quarters of the trips they undertook. The majority of travellers chose to travel by air, within Europe and for 2 or more weeks and we note that the mode of travel, destination or length of time away did not influence the proportion of patients taking their CPAP machines. This seems to show that patients do not 'make do' without CPAP if the holiday is short (<1 week). Similarly there being more space available, for example, when travelling by car or ferry, also apparently fails to influence the decision whether or not to bring the CPAP machine.
As far as the authors are aware this is the first time data has been reported regarding the behaviours and attitudes of OSAS travellers and use of their CPAP machines. In a previous study of different scope, reported at conference proceedings, 86% of OSAS patients reported travelling and took their CPAP machines on 82% of trips. 7 This is significantly more than the 63.7%, but almost identical proportion to the 81% we report for travelling and packing CPAP machines, respectively. This demonstrates that it should be assumed that our OSAS patients are travelling and indeed taking their CPAP machines along with them. Our data shows that travellers who have been on CPAP < 2 years bring their machines on holiday 100% of the time. This proportion then drops to a nadir of 68% at 2-4 years of CPAP use before rising again to >90% for those using CPAP for >4 years. The reasons for this are unclear and may benefit from further study in different population groups.
In our study the large majority of non-travellers reported no wish to travel, with only five (3.5%) reporting that the decision not to travel was CPAP related. Comments were based on concerns regarding use of the CPAP machine abroad or the nuisance of travel with the machine. In those who travelled the reasons for not taking CPAP machines were focussed on three issues: presumed difficulties with check-in, presumed difficulties with transport and a lack of baggage allowance. Reported problems with checking the machine were seen in 4% of trips, rising to 5.6% of air travel. Indeed all the problems with checking the CPAP machine were encountered as part of air travel and on 14.2% of air trips respondents reported requiring their CPAP letter. The BTS guidelines recommends patients be given a letter to carry with them and hence patients will be routinely offered this. However, our data suggests that this is not necessarily useful; the same proportion of patients had a CPAP letter whether they encountered a problem or not (70% with a problem, 74% without a problem) and respondents reported needing the CPAP letter in~10% of trips whether they encountered a 'problem' or not. In the majority (60%) of problem situations respondents stated that they had the letter but did not need it. This suggests that there are more issues around check-in than purely proving that the CPAP machine is a medical device required by the patient. However, proving that the CPAP machine is a medical device by way of a letter should allow people to carry the CPAP machine as extra cabin luggage, allaying concerns about baggage allowance.
Overnight flights made up 23.8% of flights (n = 99) in our data and half (49.5%) of respondents slept on these flights. The reasons for the other half not sleeping were not addressed in our study though one may hypothesize that perceived problems with snoring, an usual accompaniment of OSAS, maybe a factor. None of these respondents reported using CPAP during travel; the reasons for this were not covered in our questionnaire. The use of mandibular advancement devices (MAD) in OSAS is associated with significant improvement in symptoms and are well tolerated but generally considered inferior to CPAP for general use. 10 Patient focus groups show that patients have a preference for devices that are small, easy to pack and cause them the minimum of embarrassment with public use. [11] [12] [13] Some small scale studies have allowed patients the option of CPAP ± MAD use and found that patients preferred the use of MAD whilst travelling and that MAD use was associated with improved compliance. 11 Use of MAD during travel and possibly whilst away from home for short periods could therefore provide an interesting and useful alternative for patients, particularly in those that are not keen to pack or use their CPAP machines. As our data demonstrates, few patients are comfortable with the use of CPAP during travel. Such a query would benefit from further investigation.
Existing advice on travel with CPAP machines suggests bringing an extension cord and power adapters. 5 Our data also showed that the majority of problems with the CPAP machine whilst away resulted from the power cord being too short, or problems with transport, with a significant proportion having an issue with both. This finding suggests that OSAS patients are not receiving this advice regarding travel. A more widespread and thorough approach to disseminating this basic advice by leaflet, SMS or brief interventions in clinic could be an effective and simple way to reduce problems with CPAP on holiday. There are other general considerations which travellers using CPAP may be advised about. All major manufacturers of CPAP machines have produced smaller models, which are easily transported, with each new model release. If the user has an older machine they might consider requesting their CPAP provider for a newer model. If the traveller is planning on using CPAP away from mains electricity, there are several options. Most CPAP machines can be connected to a 12 V source by a cable which can be provided by the manufacturer. A rechargeable battery back will also serve the same purpose and indeed a caravan battery can be used with crocodile clips connecting the battery to the CPAP machine. An inverter, which converts variable voltages to mains voltage, may be needed in certain conditions. Rechargeable battery packs for short trips may be rented rather than being purchased, as these may be expensive. A small portable CPAP machine run via a rechargeable battery pack (Figure 1 ) provides an excellent option for those wanting to travel light. For purpose of use in a humidifier any clean water which is suitable for drinking would be suitable; this could be bottled water, water boiled then cooled, water which has passed through a filter or indeed clean tap water. For those travelling to very dusty areas, packing extra filters may be useful.
A retrospective questionnaire-based study comes with its own limitations. The response rate of 53% is similar to other studies of OSAS but we cannot rule this out a source of bias in terms of the demographics and behaviours we describe. In several areas more detail in the responses we sought from our respondents would have been useful; however, increased size of a questionnaire may lead to decreased patient engagement. Examples include descriptions of the problems involved with checking the CPAP machines and the motivation behind packing the machine. It may be that for a proportion of respondents the CPAP machine was packed to mitigate snoring and reduce disruption to the sleep partner rather than purely to treat the OSAS symptoms. This could form the basis of further study on the subject.
Conclusion
As travel, in particular air travel, becomes ever more frequent and affordable the proportion of travellers with OSAS will increase. Only a small minority of our patients stated issues surrounding CPAP as a reason not to travel and therefore airline companies should expect travellers with CPAP machines. Problems either with the power cord, adapter or transport of the CPAP machine are encountered by a significant proportion of travellers, however, these can be easily mitigated. Although a CPAP letter is given as a routine this does not appear to be associated with a difference in the number of problems encountered at check-in. None of the patients in our study used their CPAP machines whilst sleeping in flight. CPAP usage whilst away from home did not seem to differ to usage at home. This is the first report of its kind to describe in some detail the problems surrounding, and use of, CPAP machines in travel and whilst away. We hope the data may aid the targeting of brief interventions in CPAP clinics as well as helping to standardize the process of check-in, especially in air travel, in order to help travellers with CPAP machines.
Conflicts of interest: None declared. Figure 1 . A small CPAP machine which runs on a rechargeable battery pack is shown. A standard computer mouse is pictured next to the machine to help gauge the size. This type of machine was used by one of our patients on a 2-week hike, with recharging the battery pack intermittently when possible. This is one of the relatively older portable CPAP machines and the newer current ones are substantially smaller than the one depicted
